Cargando…

Therapy of Chagas Disease: Implications for Levels of Prevention

This paper reviews the evidence supporting the use of etiological treatment for Chagas disease that has changed the standard of care for patients with Trypanosoma cruzi infection in the last decades. Implications of this evidence on different levels of prevention as well as gaps in current knowledge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sosa-Estani, Sergio, Colantonio, Lisandro, Segura, Elsa Leonor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317183/ https://www.ncbi.nlm.nih.gov/pubmed/22523499 http://dx.doi.org/10.1155/2012/292138

Ejemplares similares

Integrated control of Chagas disease for its elimination as public health problem - A Review
por: Sosa-Estani, Sergio, et al.
Publicado: (2015)

Electrocardiographic Abnormalities and Treatment with Benznidazole among Children with Chronic Infection by Trypanosoma cruzi: A Retrospective Cohort Study
por: Colantonio, Lisandro D., et al.
Publicado: (2016)

Congenital Chagas disease: an update
por: Carlier, Yves, et al.
Publicado: (2015)

The Need of a Neonatal Preparation for Chagas Disease
por: Sosa-Estani, Sergio, et al.
Publicado: (2005)

COVID-19: Implications for People with Chagas Disease
por: Zaidel, Ezequiel José, et al.
Publicado: (2020)

The translational challenge in Chagas disease drug development
por: Kratz, Jadel M, et al.
Publicado: (2022)

Critical analysis of Chagas disease treatment in different countries
por: Mendes, Fernanda de Souza Nogueira Sardinha, et al.
Publicado: (2022)

Higher congenital transmission rate of Trypanosoma cruzi associated with family history of congenital transmission
por: Danesi, Emmaría, et al.
Publicado: (2020)

Human Trypanosoma cruzi chronic infection leads to individual level steady-state parasitemia: Implications for drug-trial optimization in Chagas disease
por: De Salazar, Pablo M., et al.
Publicado: (2022)

A new patient registry for Chagas disease
por: Hotez, Peter, et al.
Publicado: (2020)

Trypanocide Treatment of Women Infected with Trypanosoma cruzi and Its Effect on Preventing Congenital Chagas
por: Fabbro, Diana L., et al.
Publicado: (2014)

Cultural barriers to effective communication between Indigenous communities and health care providers in Northern Argentina: an anthropological contribution to Chagas disease prevention and control
por: Dell’Arciprete, Ana, et al.
Publicado: (2014)

Chagas disease control-surveillance in the Americas: the multinational initiatives and the practical impossibility of interrupting vector-borne Trypanosoma cruzi transmission
por: de Arias, Antonieta Rojas, et al.
Publicado: (2022)

Congenital Chagas Disease: Recommendations for Diagnosis, Treatment and Control of Newborns, Siblings and Pregnant Women
por: Carlier, Yves, et al.
Publicado: (2011)

The burden of congenital Chagas disease and implementation of molecular diagnostic tools in Latin America
por: Picado, Albert, et al.
Publicado: (2018)

WHF IASC Roadmap on Chagas Disease
por: Echeverría, Luis Eduardo, et al.
Publicado: (2020)

Text message interventions for follow up of infants born to mothers positive for Chagas disease in Tucumán, Argentina: a feasibility study
por: Cormick, Gabriela, et al.
Publicado: (2015)

The Chagas disease study landscape: A systematic review of clinical and observational antiparasitic treatment studies to assess the potential for establishing an individual participant-level data platform
por: Maguire, Brittany J., et al.
Publicado: (2021)

Role of PPARs in Trypanosoma cruzi Infection: Implications for Chagas Disease Therapy
por: Hovsepian, Eugenia, et al.
Publicado: (2012)

Cell Therapy in Chagas Disease
por: Campos de Carvalho, Antonio C., et al.
Publicado: (2009)

Fixed vs adjusted-dose benznidazole for adults with chronic Chagas disease without cardiomyopathy: A systematic review and meta-analysis
por: Ciapponi, Agustín, et al.
Publicado: (2020)

Target Product Profile (TPP) for Chagas Disease Point-of-Care Diagnosis and Assessment of Response to Treatment
por: Porrás, Analía I., et al.
Publicado: (2015)

Chagas Disease and Heart Failure: An Expanding Issue Worldwide
por: Martinez, Felipe, et al.
Publicado: (2019)

Perspectives on Adipose Tissue, Chagas Disease and Implications for the Metabolic Syndrome
por: Nagajyothi, Fnu, et al.
Publicado: (2009)

Prospective multicenter evaluation of real time PCR Kit prototype for early diagnosis of congenital Chagas disease
por: Benatar, Alejandro Francisco, et al.
Publicado: (2021)

Cytokine Networks as Targets for Preventing and Controlling Chagas Heart Disease
por: Koh, Carolina Cattoni, et al.
Publicado: (2023)

Chagas' disease and AIDS
por: Vaidian, Anil K, et al.
Publicado: (2004)

The history of Chagas disease
por: Steverding, Dietmar
Publicado: (2014)

Potential Role of Antioxidants as Adjunctive Therapy in Chagas Disease
por: Sánchez-Villamil, Juana P., et al.
Publicado: (2020)

Estrategia para mejorar el acceso al tratamiento etiológico para la enfermedad de Chagas en el primer nivel de atención en Argentina
por: Klein, Karen, et al.
Publicado: (2017)

Direct economic impact of Chagas disease treatment
por: Zaidel, Ezequiel J., et al.
Publicado: (2022)

The Costs of Preventing and Treating Chagas Disease in Colombia
por: Castillo-Riquelme, Marianela, et al.
Publicado: (2008)

Implications of asymptomatic infection for the natural history of selected parasitic tropical diseases
por: Alvar, Jorge, et al.
Publicado: (2020)

Trypanosoma cruzi loop-mediated isothermal amplification (Trypanosoma cruzi Loopamp) kit for detection of congenital, acute and Chagas disease reactivation
por: Besuschio, Susana A., et al.
Publicado: (2020)

Chagas prevention and control in an endemic area from the Argentinian Gran Chaco Region: Data from 14 years of uninterrupted intervention
por: Weinberg, Diego, et al.
Publicado: (2023)

Oxidative Stress in Chagas Disease
por: Gupta, Shivali, et al.
Publicado: (2009)

The Chronic Gastrointestinal Manifestations of Chagas Disease
por: Matsuda, Nilce Mitiko, et al.
Publicado: (2009)

Challenges in Chagas Disease Drug Development
por: Francisco, Amanda F., et al.
Publicado: (2020)

Recognition and screening for Chagas disease in the USA
por: Marcus, Rachel, et al.
Publicado: (2021)

Platelets, Macrophages, and Thromboinflammation in Chagas Disease
por: Choudhuri, Subhadip, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tef5haoa68ir33mfrttrqeh8rq